Skip to main content

Advertisement

SpringerLink
Log in

Feelings, preoperative anxiety, and need for information in patients undergoing intravitreal injections

  • Retinal Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To assess feelings, preoperative anxiety, and need for information in patients undergoing intravitreal injections (IVI).

Methods

An observational cross-sectional study was conducted in our tertiary university care center between December 2017 and December 2018. Consecutive patients undergoing IVI were included. A paper survey was completed before and after IVI to assess patient experience. Preoperative anxiety and need for information were assessed using the Amsterdam Preoperative Anxiety Information Scale (APAIS) score.

Results

Hundred patients with a median age of 76.5 years (42–95, SD = 10.1) were included. Median best-corrected visual acuity (BCVA) in both eyes was 0.4 logMAR. Main IVI indications were wet age-related macular degeneration (n = 58), diabetic macular edema (n = 19), and venous occlusion (n = 16). The IVI most unpleasant steps were as follows: using an eyelid retractor, needle entry, changing of physician from one IVI to another, the pre-IVI waiting time, and the high number of IVI required for disease control. Preoperative anxiety (APAIS score ≥ 11) was correlated in the multivariate analysis with the need for information (p = 0.004), changing of ophthalmologist between different IVI sessions (p = 0.006), and pain expected before the IVI (p = 0.010). The need for information (APAIS score ≥ 5) was only associated with the preoperative anxiety in the multivariate analysis (p = 0.001).

Conclusion

Preoperative anxiety and need for information are common in patients undergoing IVI even after many IVI. Being injected by different practitioners was strongly correlated with preoperative anxiety and should be avoided as much as possible. Better educational and information programs are needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Coleman HR, Chan C-C, Ferris FL et al (2008) Age-related macular degeneration. Lancet Lond Engl 372(9652):1835–1845

    Article  CAS  Google Scholar 

  2. Osaadon P, Fagan XJ, Lifshitz T et al (2014) A review of anti-VEGF agents for proliferative diabetic retinopathy. Eye Lond Engl 28(5):510–520

    CAS  Google Scholar 

  3. Jiang Y, Mieler WF (2017) Update on the use of anti-VEGF Intravitreal therapies for retinal vein occlusions. Asia-Pac J Ophthalmol Phila Pa 6(6):546–553

    CAS  Google Scholar 

  4. Gillies MC, Campain A, Barthelmes D et al (2015) Long-term outcomes of treatment of neovascular age-related macular degeneration: data from an observational study. Ophthalmology. 122(9):1837–1845

    Article  Google Scholar 

  5. Sloan FA, Hanrahan BW (2014) The effects of technological advances on outcomes for elderly persons with exudative age-related macular degeneration. JAMA Ophthalmol 132(4):456–463

    Article  Google Scholar 

  6. Scott IU, VanVeldhuisen PC, Ip MS et al (2017) Effect of bevacizumab vs aflibercept on visual acuity among patients with macular edema due to central retinal vein occlusion: the SCORE2 randomized clinical trial. JAMA. 317(20):2072–2087

    Article  CAS  Google Scholar 

  7. Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, Maguire MG, Martin DF et al (2016) Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: the comparison of age-related macular degeneration treatments trials. Ophthalmology. 123(8):1751–1761

    Article  Google Scholar 

  8. Eter N, Mohr A, Wachtlin J et al (2017) Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol 255(1):77–87

    Article  CAS  Google Scholar 

  9. Boyer DS, Yoon YH, Belfort R et al (2014) Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology. 121(10):1904–1914

    Article  Google Scholar 

  10. Mitchell J, Bradley C (2006) Quality of life in age-related macular degeneration: a review of the literature. Health Qual Life Outcomes 21 4:97

  11. Berdeaux GH, Nordmann J-P, Colin E et al (2005) Vision-related quality of life in patients suffering from age-related macular degeneration. Am J Ophthalmol 139(2):271–279

    Article  Google Scholar 

  12. Aroney C, Fraser-Bell S, Lamoureux EL et al (2016) Vision-related quality of life outcomes in the BEVORDEX study: a clinical trial comparing Ozurdex sustained release dexamethasone intravitreal implant and bevacizumab treatment for diabetic macular edema. Invest Ophthalmol Vis Sci 57(13):5541–5546

    Article  CAS  Google Scholar 

  13. Sivaprasad S, Oyetunde S (2016) Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion. Clin Ophthalmol Auckl NZ 10:939–946

    Article  Google Scholar 

  14. Dawson SR, Mallen CD, Gouldstone MB et al (2014) The prevalence of anxiety and depression in people with age-related macular degeneration: a systematic review of observational study data. BMC Ophthalmol 14:78

    Article  Google Scholar 

  15. Nijkamp MD, Kenens CA, Dijker AJM et al (2004) Determinants of surgery related anxiety in cataract patients. Br J Ophthalmol 88(10):1310–1314

    Article  CAS  Google Scholar 

  16. Senra H, Balaskas K, Mahmoodi N et al (2017) Experience of anti-VEGF treatment and clinical levels of depression and anxiety in patients with wet age-related macular degeneration. Am J Ophthalmol 177:213–224

    Article  CAS  Google Scholar 

  17. Boyle J, Vukicevic M, Koklanis K et al (2015) Experiences of patients undergoing anti-VEGF treatment for neovascular age-related macular degeneration: a systematic review. Psychol Health Med 20(3):296–310

    Article  Google Scholar 

  18. Senra H, Ali Z, Balaskas K et al (2016) Psychological impact of anti-VEGF treatments for wet macular degeneration-a review. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol 254(10):1873–1880

    Article  CAS  Google Scholar 

  19. Moerman N, van Dam FS, Muller MJ et al (1996) The Amsterdam Preoperative Anxiety and Information Scale (APAIS). Anesth Analg 82(3):445–451

    CAS  PubMed  Google Scholar 

  20. Maurice-Szamburski A, Loundou A, Capdevila X et al (2013) Validation of the French version of the Amsterdam Preoperative Anxiety and Information Scale (APAIS). Health Qual Life Outcomes 11:166

    Article  Google Scholar 

  21. Gayadine-Harricham Y, Amzallag T (2017) Prevalence and causes of pain after cataract surgery: comparison of 1st and 2nd eyes. J Fr Ophtalmol 40(6):505–511

    Article  CAS  Google Scholar 

  22. Wattier J-M, Barreau O, Devos P et al (2011) Measure of preoperative anxiety and need for information with six issues. Ann Fr Anesth Reanim 30(7–8):533–537

    Article  Google Scholar 

  23. Wang J-K, Huang T-L, Su P-Y et al (2015) An updated review of long-term outcomes from randomized controlled trials in approved pharmaceuticals for diabetic macular edema. Eye Sci 30(4):176–183

    PubMed  Google Scholar 

  24. Segal O, Segal-Trivitz Y, Nemet AY et al (2016) Anxiety levels and perceived pain intensity during intravitreal injections. Acta Ophthalmol 94(2):203–204

    Article  Google Scholar 

  25. Tailor R, Beasley R, Yang Y et al (2011) Evaluation of patients’ experiences at different stages of the intravitreal injection procedure - what can be improved? Clin Ophthalmol Auckl NZ 5:1499–1502

    Article  Google Scholar 

  26. Rifkin L, Schaal S (2012) Factors affecting patients’ pain intensity during in office intravitreal injection procedure. Retina Phila Pa 32(4):696–700

    Article  Google Scholar 

  27. Chua PYS, Mitrut I, Armbrecht A-M et al (2009) Evaluating patient discomfort, anxiety, and fear before and after ranibizumab intravitreous injection for wet age-related macular degeneration. Arch Ophthalmol Chic Ill 1960 127(7):939–940

    Google Scholar 

  28. Roth DB, Scott IU, Gulati N et al (2006) Patient perceptions of discomfort and changes in vision and functional status associated with intravitreal triamcinolone injection. Am J Ophthalmol 142(3):492–494

    Article  Google Scholar 

  29. Berth H, Petrowski K, Balck F (2007) The Amsterdam Preoperative Anxiety and Information Scale (APAIS) - the first trial of a German version. Psycho-Soc Med 4:Doc01

    Google Scholar 

  30. Finger RP, Fenwick E, Hirneiss CW et al (2013) Visual impairment as a function of visual acuity in both eyes and its impact on patient reported preferences. PLoS One 8(12):e81042

    Article  Google Scholar 

  31. Finger RP, Guymer RH, Gillies MC et al (2014) The impact of anti-vascular endothelial growth factor treatment on quality of life in neovascular age-related macular degeneration. Ophthalmology. 121(6):1246–1251

    Article  Google Scholar 

  32. Lee WJ, Cho HY, Kim DH et al (2013) Depression of late age-related macular degeneration patients in Korea. Asia-Pac J Ophthalmol Phila Pa 2(1):23–27

    Article  CAS  Google Scholar 

  33. Casten R, Rovner BW, Leiby BE et al (2010) Depression despite anti-vascular endothelial growth factor treatment of age-related macular degeneration. Arch Ophthalmol Chic Ill 1960 128(4):506–508

    Article  Google Scholar 

  34. Henriksen K, Adhami S (2010) Patient experience of intravitreal injections in AMD. Int J Ophthalmic Pract 1:68–72

    Article  Google Scholar 

  35. Thetford C, Hodge S, Harding S et al (2013) Living with age-related macular degeneration treatment: patient experiences of being treated with ranibizumab (Lucentis)® intravitreal injections. Br J Vis Impair 31:89–101

    Article  Google Scholar 

  36. Moisseiev E, Regenbogen M, Rabinovitch T et al (2014) Evaluation of pain during intravitreal Ozurdex injections vs. intravitreal bevacizumab injections. Eye Lond Engl 28(8):980–985

    CAS  Google Scholar 

  37. Rodriguez-Osorio CA, Dominguez-Cherit G (2008) Medical decision making: paternalism versus patient-centered (autonomous) care. Curr Opin Crit Care 14(6):708–713

    Article  Google Scholar 

  38. Feng A, O’Neill J, Holt M et al (2016) Success of patient training in improving proficiency of eyedrop administration among various ophthalmic patient populations. Clin Ophthalmol Auckl NZ 10:1505–1511

    Article  Google Scholar 

  39. Moisseiev E, Regenbogen M, Bartfeld Y et al (2014) Evaluation of pain in intravitreal bevacizumab injections. Curr Eye Res 37(9):813–817

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ophthalmology Department, University Hospital of Nice, Nice, France

    A. Martel, S. Nahon-Esteve, K. Martini & S. Baillif

  2. Neurosurgery Department, University Hospital of Nice, Nice, France

    F. Almairac

Authors
  1. A. Martel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Nahon-Esteve
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Martini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. Almairac
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Baillif
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Martel.

Ethics declarations

Conflict of interest

Baillif, Stephanie has received research grants from Allergan, Bayer, Novartis, and Horus Pharma. The other authors have no affiliation with any organization or entity with any financial interest.

Ethical approval

The study conduct was approved by the Commission Nationale Informatique et Libertés (CNIL Number: 2004024 v 0) and was performed in accordance with the ethical standards outlined by the 1964 Helsinki Declaration and its latter amendments.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Martel, A., Nahon-Esteve, S., Martini, K. et al. Feelings, preoperative anxiety, and need for information in patients undergoing intravitreal injections. Graefes Arch Clin Exp Ophthalmol 258, 1395–1403 (2020). https://doi.org/10.1007/s00417-020-04699-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-020-04699-4

Keywords

Search

Navigation